XORTX Therapeutics Statistics

Total Valuation

XRTX has a market cap or net worth of $52.89 million. The enterprise value is $47.85 million.

Market Cap	52.89M
Enterprise Value	47.85M

Important Dates

The next estimated earnings date is Tuesday, May 14, 2024, before market open.

Earnings Date	May 14, 2024
Ex-Dividend Date	n/a

Share Statistics

XRTX has 17.99 million shares outstanding. The number of shares has increased by 38.49% in one year.

Shares Outstanding	17.99M
Shares Change (YoY)	+38.49%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	4.08%
Owned by Institutions (%)	23.95%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	0.96
PS Ratio	n/a
Forward PS	n/a
PB Ratio	8.69
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.44, with a Debt / Equity ratio of 0.00.

Current Ratio	9.44
Quick Ratio	9.28
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	107.62

Financial Efficiency

Return on equity (ROE) is -105.30% and return on invested capital (ROIC) is -141.89%.

Return on Equity (ROE)	-105.30%
Return on Assets (ROA)	-85.30%
Return on Capital (ROIC)	-141.89%
Revenue Per Employee	n/a
Profits Per Employee	-$3.89M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.57% in the last 52 weeks. The beta is -0.15, so XRTX's price volatility has been lower than the market average.

Beta (1Y)	-0.15
52-Week Price Change	-55.57%
50-Day Moving Average	3.61
200-Day Moving Average	3.84
Relative Strength Index (RSI)	35.27
Average Volume (30 Days)	49,591

Short Selling Information

The latest short interest is 21,103, so 0.12% of the outstanding shares have been sold short.

Short Interest	21,103
Short Previous Month	10,519
Short % of Shares Out	0.12%
Short % of Float	n/a
Short Ratio (days to cover)	0.18

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.68M
Pretax Income	-7.78M
Net Income	-7.78M
EBITDA	-7.70M
EBIT	-7.85M
Earnings Per Share (EPS)	-$4.27

Full Income Statement

Balance Sheet

The company has $5.07 million in cash and $28,512 in debt, giving a net cash position of $5.04 million or $0.28 per share.

Cash & Cash Equivalents	5.07M
Total Debt	28,512
Net Cash	5.04M
Net Cash Per Share	$0.28
Equity / Book Value	6.09M
Book Value Per Share	0.34
Working Capital	4.67M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$10.44 million and capital expenditures -$10,527, giving a free cash flow of -$10.45 million.

Operating Cash Flow	-10.44M
Capital Expenditures	-10,527
Free Cash Flow	-10.45M
FCF Per Share	-$5.23

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-38.49%
Shareholder Yield	-38.49%
Earnings Yield	-14.70%
FCF Yield	-19.76%

Analyst Forecast

The average price target for XRTX is $14.00, which is 376.19% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	376.19%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 14, 2023. It was a reverse split with a ratio of 1:9.

Last Split Date	Nov 14, 2023
Split Type	Reverse
Split Ratio	1:9

Scores

Altman Z-Score	n/a
Piotroski F-Score	1